Syncor will be the exclusive distributor of FDG (fluorodeoxyglucose) to AmeriNet’s participating providers. The FDG agreement is an amendment to the companies’ existing radiopharmaceutical contract, which has been in place since 1997 and is
Syncor will be the exclusive distributor of FDG (fluorodeoxyglucose) to AmeriNet’s participating providers. The FDG agreement is an amendment to the companies’ existing radiopharmaceutical contract, which has been in place since 1997 and is in effect through 2002. Syncor has also signed a multiyear group purchasing agreement with InSource Health Services, a subsidiary of MedAssets.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.